Related Experiment Video
Updated: Aug 6, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
Interleukin-2 at different concentrations induces the growth of selective lymphoid cells
1Department of Genetics and Microbiology, University of Pavia, 27100 Pavia, Italy.
Insights
Recombinant interleukin-2 (rIL-2) dose impacts immune cell stimulation. Both low and high doses of rIL-2 affect peripheral blood mononucleated cells, with effects varying based on concentration.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Interleukin-2 (IL-2) is a critical cytokine in immune regulation.
- Understanding IL-2's dose-dependent effects is crucial for immunotherapy applications.
- Peripheral blood mononucleated cells (PBMCs) are key components of the adaptive and innate immune systems.
Purpose of the Study:
- To investigate the differential effects of low and high doses of recombinant interleukin-2 (rIL-2) on cultured PBMCs.
- To elucidate the dose-response relationship of IL-2 in modulating immune cell proliferation and function.
- To explore the ultrastructural and enzymatic changes induced by varying IL-2 concentrations.
Main Methods:
- Culturing of peripheral blood mononucleated cells (PBMCs).
- Treatment with varying concentrations of recombinant interleukin-2 (rIL-2).
- Assessment of cell proliferation, ultrastructural morphology, and enzymatic activity.
Main Results:
- Recombinant interleukin-2 (rIL-2) demonstrated dose-dependent effects on PBMC proliferation.
- Distinct cell types exhibited varied responses to different IL-2 concentrations.
- Ultrastructural and enzymatic analyses revealed significant alterations correlating with IL-2 dosage.
Conclusions:
- The magnitude and nature of immune cell stimulation by IL-2 are directly correlated with the administered dose.
- This study highlights the importance of precise IL-2 dosing for targeted immunomodulation.
- Findings provide insights into optimizing IL-2-based therapeutic strategies.
Abstract:
The effects of low and high doses of recombinant interleukin-2 (rIL-2) on cultured peripheral blood mononucleated cells are reported with the aim to show the effects of this immunomodulator in different conditions. The proliferation of various cell types at different IL-2 concentrations was investigated and ultrastructural and enzymatic studies were performed. The data obtained indicate that grade and type of cell stimulation induced by IL-2 is correlated to the dose employed.
Related Concept Videos
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

